PGL4001 Versus GnRH-agonist in Uterine Myomas — PEARLII

Uterine Myomas Clinical Trial

Official title:
A Phase III, Randomised, Parallel Group, Double-blind, Double-dummy, Active Comparator-controlled, Multicenter Study to Assess the Efficacy and Safety of PGL4001 vs GnRH-agonist for Pre-operative Ttt of Symptomatic Uterine Myomas

Status Completed

Clinical Trial Summary

This trial will assess the efficacy and safety of PGL4001 versus GnRH agonist, over a 3-month period for the pre-operative treatment of pre-menopausal women suffering from excessive uterine bleeding due to uterine myoma.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00740831
Study type	Interventional
Source	PregLem SA
Contact
Status	Completed
Phase	Phase 3
Start date	August 2008
Completion date	June 2010

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01048931` - Single-port Access Laparoscopic-assisted Vaginal Hysterectomy	Phase 3
Completed	`NCT00755755` - PGL4001 Versus Placebo in Uterine Myomas	Phase 3
Completed	`NCT01861015` - Vasopressin Versus Epinephrine in Myomectomy	Phase 3
Terminated	`NCT01858454` - Hand-assisted Laparoscopic Surgery (HALS) for Myomectomy	Phase 3
Completed	`NCT00874029` - Laparoscopic Radiofrequency Ablation (RFA) of Symptomatic Uterine Fibroids	N/A
Completed	`NCT00743080` - Randomized Controlled Trial (RCT)Comparing GYNAECARE MORCELLEX Versus ROTOCUT GI Tissue Morcellators	Phase 4
Recruiting	`NCT04400942` - Predictive Factors for Complete Myoma Resection During Hysteroscopic Myomectomy
Completed	`NCT01745432` - Assessment of the Manageability and Safety of ADBLOCK Adhesion Barrier System in Laparoscopic Gynaecological Surgery	Phase 1